🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to determine the safety and tolerability of SH3809...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-04-02
Trial ID
NCT04843033
Treatments Being Tested
This is a Phase I, open-label, dose escalation study of LNP3794 (BI3011441)...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2020-09-22
Trial ID
NCT05187858
Treatments Being Tested
This is a prospective one-arm, two-stage phase 2 trial of TVB-2640 in KRAS ...
Status
Active Not Recruiting
Location
University of Cincinnati
Start Date
2019-09-11
Trial ID
NCT03808558
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
This phase Ib trial studies the side effects of pembrolizumab and trametini...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-06-26
Trial ID
NCT03299088
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
This is a Phase 1/2, open-label, multicenter study designed to evaluate the...
Status
Unknown
Location
Innovative Clinical Research Institute
Start Date
2021-11-09
Trial ID
NCT05119933
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Honor Health Research Institute
Start Date
2019-07-02
Trial ID
NCT03989115
Treatments Being Tested